THE ASSOCIATION BETWEEN PSA DENSITY AND THE DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER ACROSS ALL PIRADS SCORES IN MEN WITH POSITIVE MPMRI. WHEN PSA DENSITY CAN HELP AVOIDING PROSTATE BIOPSY?

被引:0
|
作者
Pellegrino, Francesco
Gandaglia, Giorgio
Stabile, Armando
Cucchiara, Vito
Bandini, Marco
Mazzone, Elio
Rosiello, Giuseppe
Sorce, Gabriele
Pellegrino, Antony
Longoni, Mattia
Scilipoti, Pietro
Quarta, Leonardo
Zaurito, Paolo
Fossati, Nicola
Zaffuto, Emanuele
Deho, Federico
De Cobelli, Francesco
Brembilla, Giorgio
Montorsi, Francesco
Briganti, Alberto
机构
来源
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
PD39-10
引用
收藏
页码:E1049 / E1049
页数:1
相关论文
共 30 条
  • [21] Clinical-Prostate cancer A novel nomogram combined PIRADS v2 and neutrophil-to-lymphocyte ratio to predict the risk of clinically significant prostate cancer in men with PSA < 10 ng/ml at first biopsy
    Sun, JiaLe
    Zhang, ZhiYu
    OuYang, Jun
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (05) : 401 - 409
  • [22] Complexed prostate specific antigen density is better than the other PSA derivatives for detection of prostate cancer in men with total PSA between 2.5 and 20 ng/ml:: Results of a prospective multicenter study
    Sözen, S
    Eskicorapci, S
    Küpelia, B
    Irkilata, L
    Altinel, M
    Özer, G
    Uygur, C
    Alkibay, T
    Özen, H
    EUROPEAN UROLOGY, 2005, 47 (03) : 302 - 307
  • [23] MRI Fusion-Targeted Transrectal Prostate Biopsy and the Role of Prostate-Specific Antigen Density and Prostate Health Index for the Detection of Clinically Significant Prostate Cancer in Southeast Asian Men
    Tan, Teck Wei
    Png, Keng Siang
    Lee, Chau Hung
    Yuwono, Arianto
    Yeow, Yuyi
    Chong, Kian Tai
    Lee, Yee Mun
    Tan, Cher Heng
    Tan, Yung Khan
    JOURNAL OF ENDOUROLOGY, 2017, 31 (11) : 1111 - 1116
  • [24] TMPRSS2-ERG fusion prostate cancer prevalence, association with psa density, and histologic features in a multi-center US cohort of men undergoing prostate biopsy
    Mosquera, Juan M.
    Mehra, Rohit
    Regan, Meredith
    Genega, Elizabeth M.
    Gaston, Sandra
    Perner, Sven
    Bueti, Gerri
    Tomlins, Scott A.
    Shah, Rajal B.
    Wei, John T.
    Kearney, Michael
    Johnson, Laura A.
    Tang, Jeffrey M.
    Chinnaiyan, Arul M.
    Rubin, Mark A.
    Sanda, Martin G.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 705 - 706
  • [25] Initial 24-core biopsy improves the detection of clinically significant prostate cancer and high grade prostatic intraepithelial neoplasia in men with PSA less than 10 ng/ml
    Kostantinidis, C.
    Nomikos, M.
    Kariotis, I.
    Serafetinidis, E.
    Volanis, D.
    Ploumidis, A.
    McNeill, A.
    Delakas, D.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (08) : 616 - 617
  • [26] Towards a tailored use of PSA density to decide when to avoid prostate biopsy in men with PIRADS 3 lesions according to the location of the index lesion at mp-MRI. Results of a large, multi-institutional series
    Quarta, L.
    Stabile, A.
    Barletta, F.
    Mazzone, E.
    Cannoletta, D.
    Pellegrino, F.
    Sorce, G.
    Pellegrino, A.
    Cucchiara, V.
    Scuderi, S.
    Robesti, D.
    Leni, R.
    Gandaglia, G.
    Bianchi, M.
    De Cobelli, F.
    Brembilla, G.
    Roupret, M.
    Karnes, R. J.
    Montorsi, F.
    Briganti, A.
    EUROPEAN UROLOGY, 2024, 85 : S431 - S432
  • [27] TOWARDS A TAILORED USE OF PSA DENSITY TO DECIDE WHEN TO AVOID PROSTATE BIOPSY IN MEN WITH PIRADS 3 LESIONS ACCORDING TO THE LOCATION OF THE INDEX LESION AT MP-MRI. RESULTS OF A LARGE, MULTI-INSTITUTIONAL SERIES
    Quarta, Leonardo
    Stabile, Armando
    Barletta, Francesco
    Mazzone, Elio
    Cannoletta, Donato
    Pellegrino, Francesco
    Sorce, Gabriele
    Pellegrino, Antony
    Cucchiara, Vito
    Scuderi, Simone
    Robesti, Daniele
    Leni, Riccardo
    Gandaglia, Giorgio
    Bianchi, Marco
    De Cobelli, Francesco
    Brembilla, Giorgio
    Morgan, Roupret
    Karnes, R. Jeffrey
    Montorsi, Francesco
    Briganti, Alberto
    JOURNAL OF UROLOGY, 2024, 211 (05): : E313 - E313
  • [28] The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy in clinically significant prostate cancer detection in patients with biopsy-naive men according to PSA levels: A propensity score matching analysis
    Byun, Hye J.
    Shin, Teak J.
    Jung, Wonho
    Ha, Ji Y.
    Kim, Byung H.
    Kim, Young H.
    PROSTATE INTERNATIONAL, 2022, 10 (01) : 45 - 49
  • [29] PSA density improves the rate of prostate cancer detection in Chinese men with a PSA between 2.5-10.0 ng ml-1 and 10.1-20.0 ng ml-1: a multicenter study
    Lin, Yu-Rong
    Wei, Xing-Hua
    Uhlman, Matthew
    Lin, Xuan-Ting
    Wu, Si-Feng
    Diao, Peng-Fei
    Xie, Hai-Qing
    Xie, Ke-Ji
    Tang, Ping
    ASIAN JOURNAL OF ANDROLOGY, 2015, 17 (03) : 503 - 507
  • [30] The role of psa density in decision making to perform transperineal prostate biopsy in men with multi-parametric MRI Likert 2 or 3 scores: A retrospective analysis from a multi-centre cancer network study
    Fanshawe, J.
    Warren, H.
    Clark, C.
    Kum, F.
    Smekal, M.
    Masiha, E.
    Saada, L.
    Tan, C.
    Deen, S.
    Farooq, O.
    Siddiqi, M.
    Apata-Omisore, J.
    Stroman, L.
    Rusere, J.
    Tasleem, A.
    Nkwam, N. M.
    Brown, C.
    Elhage, O.
    Cathcart, P.
    Challacombe, B.
    Popert, R.
    Di Benedetto, E.
    Hadjipavlou, M.
    EUROPEAN UROLOGY, 2021, 79 : S1322 - S1322